Shps Prima Medi

Shps Prima Medi, a woman-owned limited liability company headquartered in Tbilisi, Georgia, supplies laboratory reagents, diagnostic test kits, and microbiology equipment to the Walter Reed Army Institute of Research and other federal medical research facilities as a prime contractor under full-and-open competitive procurement with no set-aside designations.

The vendor operates exclusively as a prime contractor (100% of its recent award footprint), competing for small-dollar, fixed-price purchase orders in the $17 thousand to $238 thousand range. Shps Prima Medi's capability portfolio centers on BioMerieux-compatible automated diagnostic systems (VITEK MS Prime, VITEK 2, BioFire FilmArray), culture media, PCR test kits, extraction kits, and collection and transport materials for microbiology and infectious-disease surveillance. Representative work includes a $192.6 thousand July 2026 DARPA purchase order for 35 line items of laboratory reagents and supplies for WRAIR with performance through July 30, 2027; a $98.5 thousand August 2025 DARPA order for specialized microbiology supplies through the U.S. Embassy in Tbilisi, structured as a sole-source procurement based on BioMerieux product compatibility; and a $238 thousand May 2025 Defense Health Agency purchase order for a VITEK MS PRIME automated microbial identification system.

Customer concentration is narrow and geographically anchored to the region. The Defense Advanced Research Projects Agency dominates the portfolio with seven awards ($582 thousand combined potential value), followed by the Defense Health Agency (two awards, $298 thousand), the Department of State U.S. Embassy Tbilisi (three awards, $87 thousand), the Department of the Army European Command, and the Navy Bureau of Medicine and Surgery. These five customers account for 94% of recent awards by count and 100% of combined potential value. Activity remains sparse — one award in 2024, two in 2025, one in 2026 — with $1.1 million in cumulative potential value since 2017. Two awards totaling $291 thousand face ultimate completion within the next twenty-four months and present recompete exposure for both the vendor and competitors. The vendor has no listed subcontract activity and does not sit on named federal IDIQs, GWACs, or BPAs.